Odyssey Health (ODYY) Research & Development (2021 - 2024)
Odyssey Health (ODYY) recorded quarterly Research & Development of -$10600.0 in Q3 2024, down 124.79% quarter-over-quarter from $42765.0 in Q1 2024, and up 95.25% on a YoY basis from -$5428.9 in Q3 2023.
Odyssey Health (ODYY) Research & Development (2021 - 2024) Analysis & Trends
Odyssey Health's Research & Development history runs 4 years deep, the most recent figure standing at -$10600.0 for Q3 2024.
- In Q3 2024, Research & Development rose 95.25% year-over-year to -$10600.0; the TTM figure through Apr 2025 stood at -$10600.0 (up 93.26% YoY), while the FY2024 annual figure was $55166.0, down 67.55% from the prior year.
- Research & Development was -$10600.0 for Q3 2024 at Odyssey Health, down from $42765.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $1.0 million in Q3 2021 to a low of -$223144.0 in Q3 2023.
- Historically, Research & Development has averaged $254296.5 across 4 years, with a median of $170000.0 in 2023.
- The sharpest annual moves came in 2022 and 2023: Research & Development jumped 981.03% in 2022, then sank 147.41% in 2023.
- A 4-year view of Research & Development shows it stood at $322504.0 in 2021, then advanced by 9.83% to $354215.0 in 2022, then tumbled by 93.51% to $23001.0 in 2023, then slumped by 146.08% to -$10600.0 in 2024.
- The last three Research & Development figures came in at -$10600.0 (Q3 2024), $42765.0 (Q1 2024), and $23001.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 263.30 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 345.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 145.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Odyssey Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2024 | -10,600.00 |
| Jan 31, 2024 | 42,765.00 |
| Oct 31, 2023 | 23,001.00 |
| Jul 31, 2023 | -223,144.00 |
| Jan 31, 2023 | 170,000.00 |
| Oct 31, 2022 | 354,215.00 |
| Jul 31, 2022 | 470,658.00 |
| Apr 30, 2022 | 63,139.00 |
| Jan 31, 2022 | 460,723.00 |
| Oct 31, 2021 | 322,504.00 |
| Jul 31, 2021 | 1.02 Mn |
| Apr 30, 2021 | 565,764.00 |
| Jan 31, 2021 | 42,619.00 |